Literature DB >> 11151757

Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study.

P Luppi1, M M Zanone, H Hyoty, W A Rudert, C Haluszczak, A M Alexander, S Bertera, D Becker, M Trucco.   

Abstract

AIMS/HYPOTHESIS: High frequencies of T-cell receptor (TCR) V beta 7+ T cells were detected among the lymphocytes isolated from pancreatic islets of children at the onset of Type I (insulin-dependent) diabetes mellitus. We assessed whether a preferential expression of certain TCR V beta gene families could also be detected among the peripheral blood mononuclear cells from diabetic patients.
METHODS: T-cell receptor repertoires were evaluated by using a semi-quantitative RT-PCR-based technique and confirmed by FACS analysis in peripheral blood mononuclear cells from diabetic patients before, at and after onset of the disease. These patients were also tested for exposure to enteroviruses by RT-PCR and by measuring titres of enterovirus-specific antibodies of the IgA, IgG, and IgM classes.
RESULTS: T-cell receptor V beta 7 gene family values were higher in recently-diagnosed diabetic patients (10.5% +/- 3.7) than in age-matched non-diabetic control subjects (5.1% +/- 1.6) (p < 0.001). In a time-course analysis of people who developed diabetes during clinical monitoring (i.e., converters), T-cell receptor V beta 7 gene expression showed values consistently above 10% (p < 0.0005). Long-standing diabetic patients showed lower percentage of V beta 7 expression compared to values measured at disease onset. In the longitudinal study of the converters, multiple acute enterovirus infections were also detected. These infections appeared to be temporally related to increased percentage of V beta 7 gene transcripts. CONCLUSION/
INTERPRETATION: The deviation in the T-cell receptor V beta repertoire among circulating T cells from diabetic patients seems to re-emphasize the importance of enterovirus infections in accelerating the progression of Type I diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11151757     DOI: 10.1007/s001250051559

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

Review 1.  Immune pathophysiology of aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Limited heterogeneity of T cell receptor BV usage in aplastic anemia.

Authors:  W Zeng; J P Maciejewski; G Chen; N S Young
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).

Authors: 
Journal:  Pediatr Diabetes       Date:  2007-06       Impact factor: 4.866

4.  Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.

Authors:  Anmar Khadra; Massimo Pietropaolo; Gerald T Nepom; Arthur Sherman
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

5.  Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.

Authors:  Howard R Seay; Erik Yusko; Stephanie J Rothweiler; Lin Zhang; Amanda L Posgai; Martha Campbell-Thompson; Marissa Vignali; Ryan O Emerson; John S Kaddis; Dave Ko; Maki Nakayama; Mia J Smith; John C Cambier; Alberto Pugliese; Mark A Atkinson; Harlan S Robins; Todd M Brusko
Journal:  JCI Insight       Date:  2016-12-08

Review 6.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

7.  Flow cytometric analysis of the CD4+ TCR Vβ repertoire in the peripheral blood of children with type 1 diabetes mellitus, systemic lupus erythematosus and age-matched healthy controls.

Authors:  Flora Tzifi; Maria Kanariou; Marianna Tzanoudaki; Constantinos Mihas; Evangelia Paschali; George Chrousos; Christina Kanaka-Gantenbein
Journal:  BMC Immunol       Date:  2013-08-03       Impact factor: 3.615

8.  In silico Analysis of TCR Vβ7 of Two Patients with Type 1 Diabetes Mellitus.

Authors:  Jianwei Zhou; Cui Kong; Xiukui Wang; Yinfeng Jia; Li Wang; Hong Chang; Lin Sun
Journal:  J Lab Physicians       Date:  2013-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.